REPORTS

Let’s Pullulate and Expand Your Business

Amyloglucosidase Market - Global Professional Analysis and Forecast to 2026

Oct 19, 2019  |  153 PAGES  |  REPORT CODE: CMM217945
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Amyloglucosidase market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.5% during the forecast period.

This report presents the market size and development trends by detailing the Amyloglucosidase market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Amyloglucosidase market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Amyloglucosidase industry and will help you to build a panoramic view of the industrial development.

Amyloglucosidase Market, By Type:

  • Type 1

  • Type 2

  • Type 3

Amyloglucosidase Market, By Application:

  • End-Users 1

  • End-Users 2

  • End-Users 3

Some of the leading players are as follows:

  • Shandong Longda Bio-Products Co.,Ltd.

  • DSM

  • AB Enzymes

  • VTR

  • Verenium (BASF)

  • Vland

  • Genencor (DuPont)

  • Jinyuanyang Bio-Technology Co.,Ltd.

  • Novozymes

  • YSSH

  • SunHY

  • SternEnzym

  • AB Vickers (Lallemand)

  • Sunson

  • Challenge Group

  • American Biosystems

  • Amano Enzyme

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Amyloglucosidase Market: Technology Type Analysis

  • 4.1 Amyloglucosidase Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Amyloglucosidase Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Type 1

    • 4.3.2 Type 2

    • 4.3.3 Type 3

5 Amyloglucosidase Market: Product Analysis

  • 5.1 Amyloglucosidase Product Market Share Analysis, 2018 & 2026

  • 5.2 Amyloglucosidase Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Amyloglucosidase Market: Application Analysis

  • 6.1 Amyloglucosidase Application Market Share Analysis, 2018 & 2026

  • 6.2 Amyloglucosidase Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 End-User 1

    • 6.3.2 End-User 1

    • 6.3.3 End-User 3

7 Amyloglucosidase Market: Regional Analysis

  • 7.1 Amyloglucosidase Regional Market Share Analysis, 2018 & 2026

  • 7.2 Amyloglucosidase Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Shandong Longda Bio-Products Co.,Ltd.

    • 9.1.1 Shandong Longda Bio-Products Co.,Ltd. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 DSM

    • 9.2.1 DSM Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 AB Enzymes

    • 9.3.1 AB Enzymes Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 VTR

    • 9.4.1 VTR Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Verenium (BASF)

    • 9.5.1 Verenium (BASF) Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Vland

    • 9.6.1 Vland Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Genencor (DuPont)

    • 9.7.1 Genencor (DuPont) Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Jinyuanyang Bio-Technology Co.,Ltd.

    • 9.8.1 Jinyuanyang Bio-Technology Co.,Ltd. Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Novozymes

    • 9.9.1 Novozymes Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 YSSH

    • 9.10.1 YSSH Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 SunHY

    • 9.11.1 SunHY Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 SternEnzym

    • 9.12.1 SternEnzym Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 AB Vickers (Lallemand)

    • 9.13.1 AB Vickers (Lallemand) Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Sunson

    • 9.14.1 Sunson Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Challenge Group

    • 9.15.1 Challenge Group Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 American Biosystems

    • 9.16.1 American Biosystems Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Amano Enzyme

    • 9.17.1 Amano Enzyme Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

 

The List of Tables and Figures (Totals 86 Figures and 136 Tables)

  • Figure Type 1 Amyloglucosidase market, 2015 - 2026 (USD Million)

  • Figure Type 2 Amyloglucosidase market, 2015 - 2026 (USD Million)

  • Figure Type 3 Amyloglucosidase market, 2015 - 2026 (USD Million)

  • Figure End-Users 1 market, 2015 - 2026 (USD Million)

  • Figure End-Users 2 market, 2015 - 2026 (USD Million)

  • Figure End-Users 3 market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Amyloglucosidase market, by country, 2015 - 2026 (USD Million)

  • Table North America Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table North America Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table North America Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Canada Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Canada Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Europe Amyloglucosidase market, by country, 2015 - 2026 (USD Million)

  • Table Europe Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Europe Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Europe Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Germany Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Germany Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table France Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table France Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Italy Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Italy Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Spain Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Spain Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Amyloglucosidase market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table China Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table China Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Japan Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Japan Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table India Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table India Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Amyloglucosidase market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table MEA Amyloglucosidase market, by country, 2015 - 2026 (USD Million)

  • Table MEA Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table MEA Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table MEA Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Amyloglucosidase market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Amyloglucosidase market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Amyloglucosidase market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Shandong Longda Bio-Products Co.,Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DSM Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AB Enzymes Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table VTR Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Verenium (BASF) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vland Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Genencor (DuPont) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Jinyuanyang Bio-Technology Co.,Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novozymes Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table YSSH Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table SunHY Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table SternEnzym Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AB Vickers (Lallemand) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sunson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Challenge Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table American Biosystems Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amano Enzyme Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top